![]() | CHEMLA, A., ARENA, G., SACRIPANTI, G., BARMPA, K., ZAGARE, A., GARCIA, P., GORGOGIETAS, V., ANTONY, P., OHNMACHT, J., BARON, A., Jung, J., Lind-Holm Mogensen, F., MICHELUCCI, A., MARZESCO, A.-M., BUTTINI, M., Schmidt, T., GRÜNEWALD, A., SCHWAMBORN, J. C., KRÜGER, R., & SARAIVA, C. (03 October 2025). Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss. Brain: a Journal of Neurology, 148 (10), 3607 - 3622. doi:10.1093/brain/awaf051 Peer Reviewed verified by ORBi |
![]() | GOMEZ GIRO, G., FRANGENBERG-HOFF, D., VEGA GUTIERREZ, D. M., ZAGARE, A., BARMPA, K., ANTONY, P., ROBERTSON, G., Sabahi-Kaviani, R., Haendler, K., Kruse, N., Papastefanaki, F., Matsas, R., Spielmann, M., Luttge, R., & SCHWAMBORN, J. C. (May 2025). α-Synuclein Pathology Spreads in a Midbrain-Hindbrain Assembloid Model. Advanced Science, 12 (20), 2409040. doi:10.1002/advs.202409040 Peer reviewed |
![]() | ZAGARE, A., SAUTER, T., BARMPA, K., PIRES PACHECO, M. I., KRÜGER, R., SCHWAMBORN, J. C., & SARAIVA, C. (17 April 2025). MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson's disease-associated dopaminergic neuron loss. NPJ Systems Biology and Applications, 11 (1), 37. doi:10.1038/s41540-025-00509-x Peer Reviewed verified by ORBi |
![]() | BARMPA, K., SARAIVA, C., Lopez-Pigozzi, D., Gomez-Giro, G., Gabassi, E., Spitz, S., Brandauer, K., Rodriguez Gatica, J. E., ANTONY, P., ROBERTSON, G., Sabahi-Kaviani, R., Bellapianta, A., Papastefanaki, F., Luttge, R., Kubitscheck, U., Salti, A., Ertl, P., Bortolozzi, M., Matsas, R., ... SCHWAMBORN, J. C. (23 November 2024). Modeling early phenotypes of Parkinson's disease by age-induced midbrain-striatum assembloids. Communications Biology, 7 (1), 1561. doi:10.1038/s42003-024-07273-4 Peer Reviewed verified by ORBi |
![]() | BARMPA, K. (2023). ENHANCING THE COMPLEXITY OF 3D IN VITRO MODELS FOR PARKINSON'S DISEASE RESEARCH [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/57742 |
![]() | GARCIA SANTA CRUZ, B., Sölter, J., GOMEZ GIRO, G., SARAIVA, C., SABATÉ SOLER, S., Modamio Chamarro, J., BARMPA, K., SCHWAMBORN, J. C., HERTEL, F., JARAZO, J., & HUSCH, A. (2022). Generalising from conventional pipelines using deep learning in high‑throughput screening workfows. Scientific Reports. doi:10.1038/s41598-022-15623-7 Peer Reviewed verified by ORBi |
![]() | ZAGARE, A., BARMPA, K., SMAJIC, S., SMITS, L., GRZYB, K., GRÜNEWALD, A., SKUPIN, A., NICKELS, S. L., & SCHWAMBORN, J. C. (2022). Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression. American Journal of Human Genetics. doi:10.1016/j.ajhg.2021.12.009 Peer Reviewed verified by ORBi |
![]() | SABATÉ SOLER, S., NICKELS, S. L., SARAIVA, C., Berger, E., Dubonyte, U., BARMPA, K., Lan, Y. J., Kouno, T., JARAZO, J., ROBERTSON, G., Sharif, J., Koseki, H., Thome, C., Shin, J., Cowley, S., & SCHWAMBORN, J. C. (2022). Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality. Glia. doi:10.1002/glia.24167 Peer Reviewed verified by ORBi |
![]() | JARAZO, J., BARMPA, K., Modamio, J., SARAIVA, C., SABATÉ SOLER, S., ROSETY, I., Griesbeck, A., Skwirblies, F., Zaffaroni, G., SMITS, L., Su, J., Arias-Fuenzalida, Walter, J., GOMEZ GIRO, G., Monzel, A., Qing, X., VITALI, A., CRUCIANI, G., BOUSSAAD, I., ... SCHWAMBORN, J. C. (2021). Parkinson’s disease phenotypes in patient neuronal cultures and brain organoids improved by 2-Hydroxypropyl-b-Cyclodextrin treatment. Movement Disorders. doi:10.1002/mds.28810 Peer Reviewed verified by ORBi |